Thermo Fisher Scientific (NY:TMO)

673.20 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Thermo Fisher’s (NYSE:TMO) Q1 CY2026 Sales Top Estimates

April 23, 2026

Life sciences company Thermo Fisher (NYSE:TMO) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 6.2% year on year to $11.01 billion. Its n...

Via StockStory

Thermo Fisher Scientific Reports First Quarter 2026 Results

April 23, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher (TMO) Q4 2024 Earnings Transcript ↗

April 22, 2026

Thermo Fisher (TMO) Q4 2024 Earnings Transcript

Via The Motley Fool

Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 21, 2026

Life sciences company Thermo Fisher (NYSE:TMO) will be reporting earnings this Thursday before the bell. Here’s what to look for. Thermo Fisher beat analysts...

Via StockStory

Topics Artificial Intelligence

The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down ↗

April 10, 2026

The Iran conflict has given investors a reason to sell just about everything. The Dow is in correction territory. Oil prices have surged. Entire sectors are trading as if a recession is already here....

Via MarketBeat

Topics Economy Stocks

AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages

April 09, 2026

Via Investor Brand Network

Topics Artificial Intelligence

Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics

April 09, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages

April 09, 2026

From AINewsWire

Via GlobeNewswire

3 Cash-Producing Stocks That Fall Short

April 09, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Topics Supply Chain

This Medical Device Stock Has Compounded at 13% Per Year for a Decade ↗

April 07, 2026

Thermo Fisher Scientific has outpaced the medical device sector over the past decade.

Via The Motley Fool

Topics ETFs Earnings

Unpacking Q4 Earnings: Thermo Fisher (NYSE:TMO) In The Context Of Other Research Tools & Consumables Stocks

April 06, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a...

Via StockStory

Topics Economy

Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine

April 06, 2026

In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a...

Via MarketMinute

Topics Artificial Intelligence

This Manufacturing Company That Supplies Tech, Automotive, and Communication Industries is Quietly Outperforming Its Competitors. Is the Stock a Buy in 2026? ↗

April 06, 2026

This blue chip materials stock is becoming an AI growth play.

Via The Motley Fool

Topics Artificial Intelligence

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm

April 03, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance

April 01, 2026

INDIANAPOLIS — In a move that has sent shockwaves through the global financial markets, Eli Lilly and Company (NYSE: LLY) announced early this morning, April 1, 2026, a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence Economy

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026

April 01, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗

March 29, 2026

Via MarketBeat

Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.

March 24, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Kemnay Loads Up MercadoLibre With 1,385 Shares in Q4 Buy ↗

March 04, 2026

MercadoLibre provides e-commerce and fintech solutions across Latin America, linking merchants and consumers through its digital platform.

Via The Motley Fool

Topics Regulatory Compliance

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

Via MarketMinute

Topics Earnings Economy World Trade

1 Large-Cap Stock to Target This Week and 2 Facing Challenges

February 26, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Thermo Fisher Scientific Increases Quarterly Dividend

February 25, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference

February 24, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

3 S&P 500 Stocks We’re Skeptical Of

February 23, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Intellectual Property Stocks

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

February 17, 2026

As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,...

Via Finterra

Topics Artificial Intelligence Earnings Supply Chain

Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset

February 11, 2026

Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

The Measurement Giant Reimagined: A Deep Dive into Waters Corporation (WAT) in 2026

February 10, 2026

As of February 10, 2026, Waters Corporation (NYSE: WAT) stands at the most significant crossroads in its nearly 70-year history. Long regarded as the gold standard in liquid chromatography and mass...

Via Finterra

Topics Economy

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

February 09, 2026

From Thermo Fisher Scientific Inc.

Via Business Wire

This Top Artificial Intelligence (AI) Stock Could Have More Upside in 2026 ↗

February 09, 2026

Wall Street expects Nvidia's earnings to surge this year -- and the valuation looks compelling.

Via The Motley Fool

Topics Artificial Intelligence Supply Chain

< Previous 1 2 3 4 5 6 7 8 9

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.